logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
Showing 1 - 3 of 3 Items
Showing 1 - 3 of 3 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Review

Improving equitable access for effective antibacterial: An ecosystem approach

Cohn J, Balasegaram M, Srinivasan H, Menghaney L, Mpundu M,  et al.
2025-03-01 • Clinical Microbiology and Infection
2025-03-01 • Clinical Microbiology and Infection

BACKGROUND

Antibiotics are indispensable to modern healthcare, yet their equitable access remains a pressing global challenge. Factors contributing to inequitie...

Journal Article
|
Review

25 years of the WHO essential medicines lists: progress and challenges

Laing R, Waning B, Gray A, Ford NP, 't Hoen E
2003-05-01 • Lancet
2003-05-01 • Lancet
The first WHO essential drugs list, published in 1977, was described as a peaceful revolution in international public health. The list helped to establish the principle that some medicin...
Journal Article
|
Research

Global programmatic use of bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis

Cox V, Brigden G, Crespo RH, Lessem E, Lynch S,  et al.
2018-04-01 • International Journal of Tuberculosis and Lung Disease
2018-04-01 • International Journal of Tuberculosis and Lung Disease
SETTING
The World Health Organization recommended two new drugs, bedaquiline (BDQ) and delamanid (DLM), for the treatment of multidrug-resistant tuberculosis (MDR-TB) in 2013 and 201...